Latest Breaking News On - Iopharmaceutical gnft fr0004163111 - Page 1 : comparemela.com

Cash, cash equivalents and current financial assets totaled €128.6 million as of March 31, 2023 Lille ; Cambridge, ; Zurich ; May 11, 2023 - GENFIT , a late-stage biopharmaceutical company. | May 11, 2023

France generalUnited statesUnited kingdomUncertainties of the companyTransition services agreementExchange commissionPurchase agreementPrimary biliaryNasdaq global select marketPrivate securities litigation reform actRegistration documentGenfit stock exchangePress releaseIopharmaceutical gnft fr0004163111